April 13, 2005

Lef1 in osteoblast differentiation and extracellular matrix production

Rachel Kahler

Westendorf Lab

May 11, 2005

Telomerase inhibition abrogates osseous androgen independent prostate metastasis growth in vivo: Molecular combination therapy is paradigm for a cure

Kenneth S. Koeneman, MD Dougherty Endowed Chair in Urologic Oncology

Director, Center for Prostate Cancer Department. of Urology

University of Minnesota

June 8, 2005

Targeting CK2 for cancer therapy

Khalil Ahmed, Ph.D.

Professor, Department of Laboratory Medicine and Pathology

VA Medical Center

November 9, 2005

Melanoma proteoglycan in tumor growth and survival

Jim McCarthy, Ph.D.

Professor

Department of Laboratory Medicine and Pathology

December 14, 2005

Multispectral high content cellular analysis using a flow-based imaging cytometer

Greg Veltri

Coordinator, Flow Cytometry Core Facility

University of Minnesota Cancer Center

January 11, 2006

Cap-dependent translation regulates cancer genesis and progression

Vitaly Polunovsky, Ph.D

Professor

Department of Medicine

February 8, 2006

Special Seminar

The role of macrophage stimulating protein in metastasis of breast cancer: Lesson from a new mouse model of bone metastasis

Alana L. Welm, Ph.D.

Postdoctoral Fellow

University of California-San Francisco

Cancer Progression and Metastasis Program Faculty Candidate

March 8, 2006

Special Seminar PHLPP, a novel phosphatase that terminates Akt and PKC signaling

Tianyan Gao, Ph.D.

Assistant Research Scientist

University of California at San Diego

Cancer Progression and Metastasis Program Faculty Candidate

April 12, 2006

Known by the company you keep: transcriptional co-factors of Runx2

Jennifer Westendorf, Ph.D.

Associate Professor

Department of Orthapedic Surgery

May 10, 2006

Autophagy in breast cancer progression?

Ameeta Kelekar, Ph.D.

Assistant Professor

Department of Laboratory Medicine and Pathology